• O Udruženju

Welcome

Forgot password?

Not a member? Join today

Logo
  • Početna
  • Limfom
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Koji je tvoj podtip?
  • Živeti sa limfomom
    • Korisni saveti
    • Ishrana hematoloških bolesnika
  • COVID-19
  • Resursi
    • Video edukacija
    • Brošure
    • Newsletter
  • Početna
  • Limfom
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Koji je tvoj podtip?
  • Živeti sa limfomom
    • Korisni saveti
    • Ishrana hematoloških bolesnika
  • COVID-19
  • Resursi
    • Video edukacija
    • Brošure
    • Newsletter

Sve aktuelnosti

13 Aug 2017
  • administrator
  • Novosti

Comparing genetic abnormalities and outcomes of CLL and monoclonal B-Cell lymphocytosis

This study examined genetic abnormalities monoclonal B-cell lymphocytosis (MBL). Researchers concluded that MBL was associated with similar
13 Aug 2017
  • administrator
  • Hronična limfocitna leukemija

Ibrutinib is more effective without dose interruptions in CLL

This study looked at the effect of interruptions to daily ibrutinib (Imbruvica) treatment in patients with chronic lymphocytic leukemia. This
13 Aug 2017
  • administrator
  • Hronična limfocitna leukemija

Familial chronic lymphocytic leukemia

This article reviewed what is known about familial chronic lymphocytic leukemia (fCLL). Chronic lymphocytic leukemia (CLL) can be described as
  • 1
  • 2
  • 3
  • 4

Pretraga

Novosti

  • FINDINGS FROM A RETROSPECTIVE CASE STUDY OF COVID-19 INFECTION IN CANCER PATIENTS IN WUHAN: AN EMPHASIS ON SEVERE EVENTS 04/03/2020
  • Implementation of CAR T-cell therapy in the real world – A round table discussion 04/02/2020
  • COVID-19: WHY WE SHOULD ALL WEAR MASKS — THERE IS NEW SCIENTIFIC RATIONALE 04/01/2020
  • Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies 08/06/2019
  • “Impressive” results of a new approach to relapsed or refractory Hodgkin lymphoma 06/14/2019

Arhiva

  • April 2020
  • August 2019
  • June 2019
  • May 2019
  • March 2019
  • December 2018
  • October 2018
  • June 2018
  • April 2018
  • August 2017

Kalendar

June 2023
M T W T F S S
 1234
567891011
12131415161718
19202122232425
2627282930  
« Apr    

Newsletter

Najnovije

FINDINGS FROM A RETROSPECTIVE CASE STUDY OF COVID-19 INFECTION IN CANCER PATIENTS IN WUHAN: AN EMPHASIS ON SEVERE EVENTS

1158 Days ago

Implementation of CAR T-cell therapy in the real world – A round table discussion

1159 Days ago

COVID-19: WHY WE SHOULD ALL WEAR MASKS — THERE IS NEW SCIENTIFIC RATIONALE

1159 Days ago

Pratite nas

June 2023
M T W T F S S
 1234
567891011
12131415161718
19202122232425
2627282930  
« Apr    

LIPA

Radnim danima od 10h-14h

060 022 2317

065 331 3883

e-mail: lipaserbia@gmail.com

www.lipa.org.rs

www.bloodcancer101.org.rs

www.podelizabuducnost.org.rs

PRIJATELJI UDRUŽENJA